Where does Beijing Bio-targeting Therapeutics Technology Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Beijing Bio-targeting Therapeutics Technology Inc. ranks #45,092 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is Beijing Bio-targeting Therapeutics Technology Inc.'s Innovation Score?

Beijing Bio-targeting Therapeutics Technology Inc. has an Innovation Score of 29.0 out of 100 (29th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Beijing Bio-targeting Therapeutics Technology Inc.'s patent grant rate increasing or decreasing?

Beijing Bio-targeting Therapeutics Technology Inc.'s recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Beijing Bio-targeting Therapeutics Technology Inc.'s patents?

Beijing Bio-targeting Therapeutics Technology Inc.'s patents average 4.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Beijing Bio-targeting Therapeutics Technology Inc.

Q: How many patents does Beijing Bio-targeting Therapeutics Technology Inc. hold?

Beijing Bio-targeting Therapeutics Technology Inc. holds 5 US utility patents granted between 2016 and 2022, spanning 4 technology areas.

Q: What technology areas does Beijing Bio-targeting Therapeutics Technology Inc. focus on?

Beijing Bio-targeting Therapeutics Technology Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 4 patents, ranking #2,122 of 4,144 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Q: How is the Beijing Bio-targeting Therapeutics Technology Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Beijing ranks #45,092 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.

#45,092
of 49,997 US assignees by volume: 29th percentile
by Innovation Score (29.0/100): 4.0
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45092 · Foreign Corporation #45,092 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #45,092/49,997
PHOTO-FINISH Beco Holding
CPC-NARROW C12N · 4 areas
INNOV-THIN 29.0/100
CLAIMS-SPARSE 4.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Beco Holding Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Beijing’s 29.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (21%) Velocity 13.3 pts (46%) Breadth 7.1 pts (24%) Claim depth 2.4 pts (8%)

Qualcomm Incorporated · highest

85
Beijing Bio-targetin… · this assignee

29
Nevis Industries · near

29
Nvidia Technology UK · near

29
Orlucent · near

29
Unitract Syringe PTY · near

29
3D Lighting… · lowest

7

What this shows Beijing's Innovation Score is 29.0/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Beijing?

Each dot is one of Beijing’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Beijing’s own 4.0 claims/patent is at or below the 12.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Beijing vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Beijing's grants concentrate

Beijing Bio-targeting Therapeutics Technology Inc. is a focused PatentsView assignee: 4 CPC subclasses with 80% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2016. By volume, Beijing sits between Beco Holding Limited and Beijing Hengxiang Hongye Foundation Reinforcement Technology Co., Ltd..

Beijing's three-year grant acceleration

Beijing Bio-targeting Therapeutics Technology Inc. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Beco Holding

5
Becoflex

5
Beijing Aerospace…

5
Beijing Beishute…

5
Beijing Bytedance…

5
Beijing Deepcool…

5
Beijing Deephi In…

5
Beijing Hengxiang…

5
Beijing Bio-targe… ◀

5

What this shows Beijing holds 5 patents at rank #45,066, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Beijing

By rank, the assignees closest to #45,066 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Beijing's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Beijing, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Beijing ranks #2,122 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (29 here).

Orlucent Inc. 29 Nvidia Technology UK Limited 29 Unitract Syringe PTY Ltd 29 Nevis Industries LLC 29

Beijing's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 29th percentile higher than 29% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Beijing Bio-targeting Therapeutics Technology Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	20.0%
2018	1	20.0%
2019	1	20.0%
2022	2	40.0%

Which technologies does Beijing Bio-targeting Therapeutics Technology Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

C07K - Peptides 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Beijing Bio-targeting Therapeutics Technology Inc.'s patent record in context - here's where to go next.

Beijing Bio-targeting Therapeutics Technology Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 80% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #45,092 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Beijing Bio-targeting Therapeutics Technology Inc. against Beco Holding Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.